OrbiMed Advisors LLC's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Apr 8, 2022
- Accession no.
- 0000947871-22-000450
- Filed
- Apr 8, 2022, 6:06 PM ET
- Trade date
- Apr 6-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $18.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital LLCCIK 0001157524 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 | Common Stock | SSaleDisposed | −162,000 | $20.69F1 | −$3,351,780 | 4,105,564 | Indirect | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −171,204 | $20.69F1 | −$3,542,210.76 | 731,082 | Indirect | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −167,800 | $20.66F2 | −$3,466,748 | 3,937,764 | Indirect | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −177,196 | $20.66F2 | −$3,660,869.36 | 553,886 | Indirect | |
| Apr 8, 2022 | Common Stock | SSaleDisposed | −97,200 | $20.71F3 | −$2,013,012 | 3,840,564 | Indirect | |
| Apr 8, 2022 | Common Stock | SSaleDisposed | −102,800 | $20.71F3 | −$2,128,988 | 451,086 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock ("Shares") were sold in a block at a price of $20.69.
Referenced by the price of 2 transactions in Table I.
- F2
These shares of the Issuer's common stock ("Shares") were sold in a block at a price of $20.66.
Referenced by the price of 2 transactions in Table I.
- F3
These shares of the Issuer's common stock ("Shares") were sold in a block at a price of $20.71
Referenced by the price of 2 transactions in Table I.